Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
Nicole Grabinski(Universität Hamburg), Manfred Jücker(Universität Hamburg)
Cited by 121
Related Papers
The Role of mTOR Signaling as a Therapeutic Target in Cancer
|International Journal of Molecular Sciences|2021|259
Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4
|PLoS ONE|2016|99
Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
|International Journal of Cancer|2013|86
Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
|Journal of Cancer|2015|42
All Three AKT Isoforms Can Upregulate Oxygen Metabolism and Lactate Production in Human Hepatocellular Carcinoma Cell Lines
|International Journal of Molecular Sciences|2024|6